1. Dan Han*, Qiannan Ma*, Petek Ballar, Chunyang Zhang,Min Dai, Xiaoyuan Luo, Jiong Gu, Chuansheng Wei,Panhui Guo, Lulu Zeng, Min Hu, Can Jiang, Yanyan Liang, Yanyan Wang, Chao Hou, Xian Wang, Lijie Feng,Yujun Shen, Yuxian Shen*, Xiangpeng Hu#, Jun Liu (刘珺) #. Reprogramming tumor-associated macrophages and inhibiting tumor neovascularization by targeting MANF-HSF1-HSP70-1 pathway: An effective treatment for hepatocellular carcinoma, Acta Pharmaceutica Sinica B, 2024, Accepted. 中科院一区，TOP期刊，IF=14.7分
2. Can Jiang*, Chunyang Zhang*, Min Dai*, Fuyan Wang, Sa Xu, Dan Han, Yanyan Wang, Yajie Cao, Yanyan Liang, Ziyu Zhang, Lina Yan, Yujun Shen, Kewu He, Yuxian Shen#, Jun Liu (刘珺)#. Interplay between SUMO1-related SUMOylation and phosphorylation of p65 promotes hepatocellular carcinoma progression. Biochim Biophys Acta Mol Cell Res. 2024 Jan;1871(1):119595. 中科院2区，IF=5.1分
3. Chengyue Zhou, Dan Han, Hui Fang, Dake Huang, Heping Cai, Yujun Shen, Yuxian Shen#, Jun Liu (刘珺) #. Deletion of mesencephalic astrocyte-derived neurotrophic factor delays and damages the development of white pulp in spleen. Immunobiology. 2024 Jan;229(1):152778.
4. Hu XP*, Han D*, Wang YY, Gu J, Wang X, Jiang YF, Yang Y#, Liu J (刘珺)#. 2021. Phospho-Smad3L promotes progression of hepatocellular carcinoma through decreasing miR-140-5p level and stimulating epithelial-mesenchymal transition. Digestive and Liver Disease (IF=4.088). 2021 Mar 25; S1590-8658(21)00096-7. doi: 10.1016/j.dld.2021.03.003.
5. Liu J（刘珺）*, Wu Z*, Han D, Wei C, Liang Y, Jiang T, Chen L, Sha M, Cao Y, Huang F, Geng X, Yu J, Shen Y, Wang H, Feng L, Wang D, Fang S, Wang S#, Shen Y#. 2020. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-κB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition. Hepatology (IF=17.425). 2020. 71(4): 1262-1278. 中科院一区，TOP期刊，ESI高被引
6. Yang Y*, Wang P, Zhang C, Huang F, Pang G, Wei C, Lv C, Chhetri G, Jiang T, Liu J（刘珺）, Shen Y, Shen Y#. Hepatocyte-derived MANF alleviates hepatic ischemia-reperfusion injury via regulating endoplasmic reticulum stress-induced apoptosis in mice. Liver International. 2020. Oct 16. Doi:10.1111/liv.14697.
7. Wang P*, Yang Y, Pang G, Zhang C, Wei C, Tao X, Liu J（刘珺）, Xu J, Zhang W, Shen Y#. Hepatocyte-derived MANF is protective for rifampicin-induced cholestatic hepatic injury via inhibiting ATF4-CHOP signal activation. Free Radical Biology [and] Medicine. 2020 Oct 28; S0891-5849(20)31302-2. Doi: 10.1016/j.freeradbiomed. 2020.10.028
8. Hou C, Wang D, Li X, He Y, Wei C, Jiang R, Liu J（刘珺）, Feng L, Shen Y#. 2019. MANF regulates splenic macrophage differentiation in mice. Immunol Lett (IF=2.552). 2019 Aug; 212:37-45.
9. Zhang W*, Chen L, Feng H, Wang W, Cai Y, Qi F, Tao X, Liu J（刘珺）, Shen Y, Ren X, Chen X, Xu J#, Shen Y#. 2017. Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression [and] enhancing the Nrf2-mediated adaptive response. Free Radic Biol Med (IF=5.657). 2017 Nov; 112: 24-35.
10. Liu J（刘珺）, Tao X, Zhang J, Wang P, Sha M, Ma Y, Geng X, Feng L, Shen Y, Yu Y, Wang S, Fang S, Shen Y#. Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation. Oncotarget. 2016, 7(16): 22206-18.（IF=6.359）
11. Liu J（刘珺）, Sha M, Wang Q, Ma Y, Geng X, Gao Y, Feng L, Shen Y, Shen Y#. Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma. BMC Cancer. 2015, Oct 12;15:675.（IF=3.362）
12. Liu J（刘珺）, Zhou C, Tao X, Feng L, Wang X, Chen L, Li C, Huang D, Fang S, Shen Y#. ER stress-inducible protein MANF selectively expresses in human spleen. Human Immunology. 2015, 76(11):823-30. （IF=2.138）
